A component of innate immunity prevents bacterial biofilm development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infection. These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infections. In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistence. The transition from a free-living, independent existence to a biofilm lifestyle can be devastating, because biofilms notoriously resist killing by host defence mechanisms and antibiotics. We hypothesized that the innate immune system possesses specific activity to protect against biofilm infections. Here we show that lactoferrin, a ubiquitous and abundant constituent of human external secretions, blocks biofilm development by the opportunistic pathogen Pseudomonas aeruginosa. This occurs at lactoferrin concentrations below those that kill or prevent growth. By chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing the bacteria to wander across the surface instead of forming cell clusters and biofilms. These findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in biofilm development, the time bacteria stop roaming as individuals and aggregate into durable communities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its iron-free form, apo-LF, inhibits the formation of biofilms by P. aeruginosa (Singh et al., 2002).”
From Iron in infection and immunity (2020) · cites this paper as Singh et al., 2002
In the citing paper
“The Fe-binding capacity of lactoferrin can also interfere with microbial virulence pathways such as biofilm formation [122].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [122]
In the citing paper
“There are other examples, indicating a beneficial effect of targeting Fe, as illustrated for the ability of lactoferrin to prevent bacterial biofilm formation [122].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [122]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Self-citationThe Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 1×
“Methods Bacterial strains, plasmids, and growth conditions Pseudomonas aeruginosa strain PAO1 containing the GFP plasmid pMRP9-1 (ref”
BackgroundSelf-citationFlagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,492 · cited 1×
“This led us to hypothesize that mucosal surfaces might possess an anti-biofilm defence, perhaps using antimicrobial factors, a phylogenetically conserved limb of the innate immune syste”
BackgroundQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519 · cited 1×
“In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistenc”
BackgroundSelf-citationWeinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198 · cited 1×
“These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infection”
BackgroundAlginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693 · cited 1×
“Pseudomonas aeruginosa biofilms for susceptibility tests were grown in a rotating disc reacto”
MethodSelf-citationThe Biochemistry of Desferrioxamine and its Relation to Iron Metabolism
Keberle, H. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54077.x · Cited by 612
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Development and Dynamics of Pseudomonas sp. Biofilms
Tolker-Nielsen, T., Brinch, U. C., Ragas, P. C., Andersen, J. B., Jacobsen, C. S., & Molin, S. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.22.6482-6489.2000 · Cited by 335 · cited 1×
“2a–d ), we observed the typical stages of biofilm developmen”
BackgroundBiofilm resistance to antimicrobial agents
Xu, K. D., McFeters, G. A., & Stewart, P. S. (2000) · Microbiology · doi:10.1099/00221287-146-3-547 · Cited by 325
Innate Antimicrobial Activity of Nasal Secretions
Cole, A. M., Dewan, P., & Ganz, T. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3267-3275.1999 · Cited by 292 · cited 1×
“jpg" NDATA ITEM> ]> Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infectio”
BackgroundBritigan, B. E., Hayek, M. B., Doebbeling, B. N., & Fick, R. B. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5049-5055.1993 · Cited by 156
Thompson, A. B., Bohling, T., Payvandi, F., & Rennard, S. I. (1990) · PubMed · Cited by 149
Kolter, R., & Losick, R. (1998) · Science · doi:10.1126/science.280.5361.226 · Cited by 143
Jeong, B. C., Hawes, C., Bonthrone, K. M., & Macaskie, L. E. (1997) · Microbiology · doi:10.1099/00221287-143-7-2497 · Cited by 143 · cited 1×
“We also studied deferoxamine, an iron chelator unrelated to lactoferrin that has a lower iron-binding affinity than lactoferri”
BackgroundThe Effects of Lactoferrin on Gram-Negative Bacteria
Ellison, R. T. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2548-6_8 · Cited by 139
The Zinc-Reversible Antimicrobial Activity of Neutrophil Lysates and Abscess Fluid Supernatants
Sohnle, P. G., Collins-Lech, C., & Wiessner, J. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.1.137 · Cited by 137
Martin, P. R., Watson, A. A., McCaul, T. F., & Mattick, J. S. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02414.x · Cited by 116
STITES, S. W., PLAUTZ, M. W., BAILEY, K., O'BRIEN-LADNER, A. R., & WESSELIUS, L. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9811018 · Cited by 109 · cited 1×
“Other reports have shown that the levels of free iron are increased in airway secretions of cystic fibrosis patient”
BackgroundStites, S. W., Walters, B., O'Brien-Ladner, A. R., Bailey, K., & Wesselius, L. (1998) · CHEST Journal · doi:10.1378/chest.114.3.814 · Cited by 105 · cited 1×
“Other reports have shown that the levels of free iron are increased in airway secretions of cystic fibrosis patient”
BackgroundConcentrations of lactoferrin and iron in human milk at different stages of lactation.
HIRAI, Y., KAWAKATA, N., SATOH, K., IKEDA, Y., HISAYASU, S., ORIMO, H., & YOSHINO, Y. (1990) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.36.531 · Cited by 99
Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin
Leitch, E. C., & Willcox, M. D. P. (1999) · Current Eye Research · doi:10.1076/ceyr.19.1.12.5342 · Cited by 89 · cited 1×
“Lactoferrin can also be bactericidal by binding lipopolysaccharide and disrupting bacterial membranes, and it can enhance killing by other antibiotic”
BackgroundIron and Infection: New Development and Their Implications
Ward, C. G., Bullen, J. J., & Rogers, H. J. (1996) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199608000-00030 · Cited by 81
Antimicrobial proteins and peptides in host defense1
Ganz, T. (2001) · Seminars in Respiratory Infections · doi:10.1053/srin.2001.22723 · Cited by 52 · cited 1×
“jpg" NDATA ITEM> ]> Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infectio”
BackgroundLysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease.
Harbitz, O., JENSSEN, A. O., & Smidsrød, O. (1984) · PubMed · Cited by 51
The role of extracellular bactericidal factors in pulmonary host defense.
Coonrod, J. D. (1986) · PubMed · Cited by 48
Decreased tear lactoferrin concentration in patients with chronic hepatitis C
Abe, T., Nakajima, A., Matsunaga, M., Sakuragi, S., & Komatsu, M. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.6.684 · Cited by 46
Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.
Burns, J. L., Ramsey, B. W., & Smith, A. L. (1993) · PubMed · Cited by 40
Samson, R. R., Mirtle, C. L., & McClelland, D. B. L. (1979) · PubMed · Cited by 23
Research works printed but not linked: 1
- Xiao, R. & Kisaalita, W. S. Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin. Microbiology 143, 2509–2515 (1997) · DOI · Paper page
Cited by
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
“However, recognition that antimicrobial peptides have targets other than membranes, such as lactoferrin, which blocks biofilm development by opportunistic pathogen”
BackgroundHepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
“[208], lactoferrin was found to block biofilm formation of P.”
BackgroundAttenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Metadata
- Authors
- Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J.
- Affiliations
- University of Iowa (US)
- Northwestern University (US)
- Corresponding author
- Singh, Pradeep K.
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6888
- Pages
- 552-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1970294462
- Cited by
- 1,026
- References
- 31
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 24 · 2023: 35 · 2022: 34 · 2021: 45 · 2020: 37 · 2019: 33 · 2018: 43 · 2017: 43 · 2016: 43 · 2015: 52 · 2014: 55 · 2013: 37 · 2012: 69
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (K24HL102246)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- lactoferrin, bacterial biofilm formation, Pseudomonas aeruginosa, innate immunity, iron chelation, twitching motility, surface motility, mucosal protection, chronic bacterial infection
- MeSH terms
- Chronic Disease, Conalbumin, Dose-Response Relationship, Drug, Humans, Hydrogen Peroxide, Immunity, Innate, Iron, Iron Chelating Agents, Lactoferrin, Pseudomonas aeruginosa, Tobramycin, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.